Great West Life Assurance CO Biotechnology

Great West Life Assurance CO

$56.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AXSM Axsome Therapeutics, Inc.	$4.82B	$364,000 0.0% of portfolio	3,112	Q4 2024 Reduced 7.13%
ARDX Ardelyx, Inc.	$693M	$304,000 0.0% of portfolio	61,922	Q1 2025 Added 250.44%
KYMR Kymera Therapeutics, Inc.	$2.46B	$288,000 0.0% of portfolio	10,491	Q2 2024 Added 166.88%
IDYA Ideaya Biosciences, Inc.	$1.02B	$259,000 0.0% of portfolio	15,807	Q2 2024 Added 42.42%
SNDX Syndax Pharmaceuticals Inc	$557M	$254,000 0.0% of portfolio	20,662	Q2 2024 Added 187.69%
GERN Geron Corp	$518M	$240,000 0.0% of portfolio	150,298	Q1 2025 Added 4.38%
XENE Xenon Pharmaceuticals Inc.	$2.03B	$236,000 0.0% of portfolio	7,024	Q1 2025 Reduced 55.85%
MDXG Mimedx Group, Inc.	$736M	$228,000 0.0% of portfolio	29,938	Q1 2025 Reduced 27.04%
ARQT Arcutis Biotherapeutics, Inc.	$957M	$201,000 0.0% of portfolio	12,816	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$317M	$198,000 0.0% of portfolio	59,463	Q1 2025 Added 3.84%
DNLI Denali Therapeutics Inc.	$1.97B	$183,000 0.0% of portfolio	13,434	Q2 2024 Added 38.15%
BEAM Beam Therapeutics Inc.	$1.49B	$174,000 0.0% of portfolio	8,895	Q1 2025 Added 4.24%
AKRO Akero Therapeutics, Inc.	$2.39B	$164,000 0.0% of portfolio	4,050	Q3 2023 Added 172.54%
APLS Apellis Pharmaceuticals, Inc.	$2.19B	$136,000 0.0% of portfolio	6,189	Q4 2024 Reduced 22.93%
CLDX Celldex Therapeutics, Inc.	$1.09B	$115,000 0.0% of portfolio	6,338	Q3 2024 Reduced 53.46%
ARVN Arvinas, Inc.	$419M	$102,000 0.0% of portfolio	14,524	Q2 2024 Reduced 18.06%
IMVT Immunovant, Inc.	$3.55B	$102,000 0.0% of portfolio	5,987	Q1 2025 Reduced 58.06%
OCUL Ocular Therapeutix, Inc	$770M	$88,000 0.0% of portfolio	11,976	Q1 2025 Reduced 60.38%
NTLA Intellia Therapeutics, Inc.	$908M	$82,000 0.0% of portfolio	11,469	Q1 2025 Reduced 55.1%
NVAX Novavax Inc	$545M	$76,000 0.0% of portfolio	11,763	Q1 2024 Reduced 0.52%
STOK Stoke Therapeutics, Inc.	$461M	$73,000 0.0% of portfolio	10,889	Q1 2025 Added 12.07%
ADPT Adaptive Biotechnologies Corp	$1.65B	$72,000 0.0% of portfolio	9,655	Q1 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$355M	$58,000 0.0% of portfolio	5,464	Q1 2025 Reduced 0.27%
NRIX Nurix Therapeutics, Inc.	$583M	$55,000 0.0% of portfolio	4,636	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$426M	$46,000 0.0% of portfolio	8,324	Q2 2024 New
GMAB Genmab A/S	$14.1B	$44,000 0.0% of portfolio	2,264	Q1 2025 Added 44.48%
REPL Replimune Group, Inc.	$556M	$43,000 0.0% of portfolio	4,393	Q3 2023 Added 208.5%
RCKT Rocket Pharmaceuticals, Inc.	$231M	$42,000 0.0% of portfolio	6,276	Q4 2023 Added 25.85%
KURA Kura Oncology, Inc.	$425M	$41,000 0.0% of portfolio	6,268	Q1 2025 Reduced 64.86%
ANNX Annexon, Inc.	$131M	$29,000 0.0% of portfolio	14,935	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$428M	$23,000 0.0% of portfolio	8,624	Q3 2023 Added 154.02%
ALT Altimmune, Inc.	$217M	$22,000 0.0% of portfolio	4,354	Q1 2024 New
RGNX Regenxbio Inc.	$376M	$21,000 0.0% of portfolio	2,915	Q1 2025 Reduced 56.16%
SVRA Savara Inc	$261M	$20,000 0.0% of portfolio	7,047	Q1 2024 New
ALLO Allogene Therapeutics, Inc.	$186M	$19,000 0.0% of portfolio	12,897	Q1 2025 Reduced 36.86%
PHAT Phathom Pharmaceuticals, Inc.	$344M	$18,000 0.0% of portfolio	2,839	Q3 2023 Added 234.0%
FATE Fate Therapeutics Inc	$111M	$16,000 0.0% of portfolio	20,401	Q1 2025 Reduced 4.07%
EDIT Editas Medicine, Inc.	$196M	$10,000 0.0% of portfolio	8,425	Q1 2025 Added 18.05%
PLRX Pliant Therapeutics, Inc.	$58.9M	$7,000 0.0% of portfolio	5,486	Q3 2023 Added 193.21%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.